Senzar Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-59,300
Closed -$10.1M 26
2018
Q1
$10.1M Buy
+59,300
New +$10.9M 3.19% 13
2016
Q3
Sell
-155,932
Closed -$23.7M 38
2016
Q2
$23.7M Sell
155,932
-113,368
-42% -$17.6M 5.17% 6
2016
Q1
$40.4M Buy
+269,300
New +$40M 8.02% 2
2015
Q4
Sell
-207,400
Closed -$28.7M 42
2015
Q3
$28.7M Buy
+207,400
New +$32.7M 4.17% 7
2014
Q3
Sell
-119,298
Closed -$14.1M 30
2014
Q2
$14.1M Sell
119,298
-8,800
-7% -$1.02M 5.39% 8
2014
Q1
$15.8M Buy
128,098
+44,298
+53% +$5.37M 8.37% 5
2013
Q4
$9.56M Buy
+83,800
New +$9.53M 7.81% 6

Other funds holding AMGN

Senzar Asset Management's AMGN Position: Q2 2018 in Review

Senzar Asset Management sold out of Amgen (AMGN) in Q2 2018, closing a stake of 59,300 shares — an estimated $10.1M sold.

Senzar Asset Management first reported a position in AMGN in Q4 2013 and held it in 7 quarters. The position peaked at $40.4M in Q1 2016. 1,763 funds tracked by Wall St. Rank hold AMGN as of Q2 2018.

  • Senzar Asset Management reported no remaining Amgen position as of Q2 2018 after selling out during the quarter.
  • Senzar Asset Management sold 59,300 Amgen shares in Q2 2018, an estimated $10.1M.
  • Senzar Asset Management first reported a position in Amgen in Q4 2013 and held it in 7 quarters.
  • Senzar Asset Management's Amgen position peaked at $40.4M in Q1 2016.
  • 1,763 funds tracked by Wall St. Rank held Amgen as of Q2 2018.

Based on Senzar Asset Management's 13F filing for Q2 2018, filed 13 Aug 2018.